Dr Thomas Newsom-Davis, Consultant Medical Oncologist
Dr Thomas Newsom-Davis
Consultant Medical Oncologist
Dr Thomas Newsom-Davis BSc MBBS FRCP PhD
Consultant Medical Oncologist
Dr Thomas Newsom-Davis
Consultant Medical Oncologist BSc MBBS FRCP PhD
Areas of expertise
- Chemotherapy
- Lung cancer
- Mesothelioma
- Thymus gland cancer
- Primary lung tumours
Recommendations for Dr Newsom-Davis
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
-
Platinum Medical Centre
15 - 17 Lodge Road, London, NW8 7JA
-
Sydney Street Outpatients and Diagnostics Centre
102 Sydney Street, London, SW3 6NJ
About Dr Thomas Newsom-Davis
GMC number: 4529260
Year qualified: 1998
Place of primary qualification: University of London
Dr Thomas Newsom-Davis is a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, with a particular focus on lung cancer and mesothelioma. In 2015, he was honoured with the Macmillan Innovation Excellence Award.
Dr Newsom-Davis completed his medical training at University College and Middlesex School of Medicine, London, in 1998, achieving First Class honours for his BSc. He further specialised in medical oncology at Charing Cross and Hammersmith Hospitals and earned a PhD in tumour immunology. He was appointed to Chelsea and Westminster Hospital in 2010.
Currently, Dr Newsom-Davis leads the lung cancer service at Chelsea and Westminster Hospital. He also serves as Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organisation dedicated to supporting and educating thoracic oncology professionals across the United Kingdom. Additionally, he is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT) and Chair of the HCA Healthcare UK Thoracic Oncology Board.
Dr Newsom-Davis maintains an active clinical trial portfolio and has presented his research at both national and international conferences. He has been an invited lecturer for prestigious organisations such as the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association, and the Association of Cancer Physicians.
His areas of expertise include immunotherapy, targeted therapy, and chemotherapy, with a focus on treating lung cancer and mesothelioma. Dr Newsom-Davis is committed to advancing the field of thoracic oncology and providing the highest standard of care to his patients.
Areas of expertise
- Lung Cancer
- Mesothelioma
- Acute Oncology
- Other thoracic malignancies
- Medical Oncology
- Breast Cancers
Professional memberships
Articles by Dr Thomas Newsom-Davis
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy